Facilitation of passive avoidance response by newly synthesized cationized arginine vasopressin fragment 4-9 in rats

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 1-2, 1997, Pages 251-256

  Tanabe, Shuichi ^a   Shishido, Yoshiyuki ^a   Furushiro, Masayoshi ^a   Kado, Kunio ^a   Hashimoto, Shusuke ^a   Yokokura, Teruo ^a   Ohsawa, Toshiaki ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Arginine vasopressin; C APV (4 9); Central Nervous System; Passive avoidance response; Rats

Indexed keywords

ARGIPRESSIN DERIVATIVE; ARGIPRESSIN[4-9];

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG PENETRATION; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ARGININE VASOPRESSIN; AVOIDANCE LEARNING; BRAIN; CATIONS; DRUG EVALUATION, PRECLINICAL; INJECTIONS, INTRAVENOUS; MALE; MEMORY; MICE; MICE, INBRED ICR; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RETENTION (PSYCHOLOGY);

ANIMALIA;

EID: 0030953567     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00346-2     Document Type: Article

References (28)

1. Ader, R., Weijnen, J. A. W. M., Moleman, P. Retention of a passive avoidance response as a function of the intensity and duration of electric shock. Psycon. Sci. 26: 125-128; 1972.
2. Bischoff, K. B., Dedrick, R. L., Zaharko, D. S. Preliminary model for methotrexate pharmacokinetics. J. Pharm. Sci. 59: 149-154; 1970.
3. Burbach, J. P. H., Kovács, G. L., De Wied, D., Van Nispen, J. W., Greven, H. M. A major metabolite of arginine vasopressin in the brain is highly potent neuropeptide. Science 221: 1310-1312; 1983.
4. Burbach, J. P. H., Lebouille, J. L. M. Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membrane. J. Biol. Chem. 258: 1487-1494; 1983.
5. Burbach, J. P. H., De Bree, F. M., Terwel, D., Tan, A., Maskova, H. P., Van Der Kleij, A. A. M. Properties of aminopeptidase activity involved in the conversion of vasopressin by rat brain membranes. Peptides 14: 807-813; 1993.
6. Cefalu, W. T., Pardridge, W. M. Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier. J. Neurochem. 45: 1954-1956; 1985.
7. De Wied, D., Gaffori, O., Van Ree, J. M., De Jong, W. Central target for the behavioural effects of vasopressin neuropeptides. Nature 308: 276-278; 1984.
8. De Weid, D., Gaffori, O., Burbach, J. P. H., Kovács, G. L., Van Ree, J. M. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J. Pharmacol. Ther. 241: 268-274; 1987.
9. Du, Y., Wu, J., Jiang, X., Gu, Y. Characterization of binding sites of a memory-enhancing peptide AVP (4-8) in rats cortical synaptosomal membranes. Peptides 15: 1273-1279 ; 1994.
10. Gaffori, O. J. W., De Wied, D. Time-related memory effects of vasopressin analogues in rats. Pharmacol. Biochem. Behav. 25: 1125-1129; 1986.
11. Hunter, W. M, Greenwood, F. C. Preparation of iodine 131 labelled human growth hormone of high specific activity. Nature 194; 495-496; 1962.
12. Jurzak, M., Müller, A. R., Gerstberger, R. Characterization of vasopressin receptors in cultured cells derived from the region of rat brain circumventricular organs. Neuroscience 4: 1145-1159; 1995.
13. Kovács, G. L., Veldhuis, H. D., Versteeg, D. H. G., De Wied, D. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures. Brain Res. 371: 17-24; 1986.
14. Mike, A., Ohya, Y., Ohwaki, M., Sakai, M., Sako, T., Watanabe, T., Yokokura, T. Measurement of staphylokinase by enzyme-linked immunosorbent assay using monoclonal antibodies. Biol. Pharm. Bull. 17: 564-567; 1994.
15. Pardridge, W. M., Triguero, D., Buciak, J. Transport of histone through the blood-brain barrier. J. Pharmacol. Exp. Ther. 251: 821-826; 1989.
16. Pardridge, W. M., Triguero, D., Buciak, J., Yang, J. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector. J. Pharmacol. Exp. Ther. 255: 893-899; 1990.
17. Pardridge. W. M. Recent developments in peptide drug delivery to the brain. Pharmacol. Toxicol. 71: 3-10; 1992.
18. Shen, Y., Li, R. The role of neuropeptides in learning and memory: possible mechanisms. Medical Hypotheses 45: 529-538; 1995.
19. Shimura, T., Tabata, S., Terasaki, T., Deguchi, Y., Tsuji, A. Invivo blood-brain barrier transport of a novel adrenocorticotropic hormone analogue, ebiratide, demonstrated by brain microdialysis and capillary depletion methods. J. Pharm. Pharmacol. 44: 583-588; 1992.
20. Terasaki, T., Iga, T., Sugiyama, Y., Hanano, M. Pharmaco-kinetic study on the mechanism of tissue distribution of doxorubicin: Interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits and guinea pigs. J. Pharm. Sci. 73: 1359-1363; 1984.
21. Terasaki, T., Takakuwa, S., Saheki, A., Moritani, S., Shimura, T., Tabata, S., Tsuji, A. Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: Studies with monolayers of primary cultured bovine brain capillary endothelial cells. Pharm. Res. 9: 529-534; 1992.
22. Terasaski, T., Tsuji, A. Drug delivery to the brain utilizing blood-brain barrier transport systems. J. Controlled Release 29: 163-169; 1994.
23. Triguero, D., Buciak, J., Pardridge, W. M. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 54: 1882-1888; 1990.
24. Van Bree, J. B. M. M., De Boer, A. G., Verhoef, J. C., Danhof, M., Breimer, D. D. Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells. J. Pharmacol. Exp. Ther. 249: 901-905; 1989.
25. Wilk, S., Orlowski, M. Inhibition of rabbit brain prolyl endopeptidase by N-benzyloxycarbonyl-prolyl-prolinal, a transition state aldehyde inhibitor. J. Neurochem. 41: 69-75; 1983.
26. Yamaoka K., Tanigawara, Y., Nakagawa, T., Uno, T. Pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharm. Dyn. 4: 879-885; 1980.
27. Yoshimoto, T., Nishimura, T., Kita, T., Tsuru, D. Post-proline cleaving enzyme (prolyl endopeptidase) from bovine brain. J. Biochem. 94: 1179-1190; 1983.
28. Zlokovic, B. V., Mackic, J. B., Lipovac, M. N., McComb, J. G., Weiss, M. H. Blood-brain transport of vasopressin. Adv. Exp. Med. Biol. 331: 143-147; 1993.